Get the Stockscreener App
2.85
6.74%
0.18
Anebulo Pharmaceuticals Inc stock is traded at $2.85, with a volume of 141.35K.
It is up +6.74% in the last 24 hours and up +62.86% over the past month.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
See More
Previous Close:
$2.67
Open:
$2.7
24h Volume:
141.35K
Relative Volume:
1.91
Market Cap:
$117.09M
Revenue:
-
Net Income/Loss:
$-7.92M
P/E Ratio:
-9.50
EPS:
-0.3
Net Cash Flow:
$-7.05M
1W Performance:
-10.66%
1M Performance:
+62.86%
6M Performance:
+85.58%
1Y Performance:
+24.85%
1-Day Range:
$2.67
$2.92
1-Week Range:
$2.67
$3.20
52-Week Range:
$0.8001
$3.39
Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile
Name
Anebulo Pharmaceuticals Inc
Sector
Industry
Phone
737 203 5270
Address
C/O ANEBULO PHARMACEUTICALS, INC., LAKEWAY
Compare ANEB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
2.85 | 109.70M | 0 | -7.92M | -7.05M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Anebulo Pharmaceuticals Inc Stock (ANEB) Latest News
Using Ichimoku Cloud for Anebulo Pharmaceuticals Inc. technicalsBear Market Safe Zone Technical Analysis - Newser
What makes Anebulo Pharmaceuticals Inc. stock price move sharplySmart Portfolio Entry Points With Low Risk - jammulinksnews.com
What are analysts’ price targets for Anebulo Pharmaceuticals Inc. in the next 12 monthsEarnings Report Guidance For Smart Trading - jammulinksnews.com
Volume spikes in Anebulo Pharmaceuticals Inc. stock – what they meanFree ROI Boosting Trade Opportunity Calendar - Newser
Analyzing Anebulo Pharmaceuticals Inc. with multi timeframe chartsMachine Learning Stock Movement Detector - Newser
Is it the right time to buy Anebulo Pharmaceuticals Inc. stockPre Market Recommendation With Low Risk - jammulinksnews.com
Will Anebulo Pharmaceuticals Inc. stock recover after recent dropTrade Alert System with Volume Analysis - Newser
How Resilient Is Anebulo Pharmaceuticals Inc. Stock During Economic DownturnsDaily Growth Stock Pick Reports Show Bullish Signals - metal.it
Screener Results Flag Anebulo Pharmaceuticals Inc. as OversoldConsistent Profit Pattern Recognition Tools Shared - metal.it
How Anebulo Pharmaceuticals Inc. stock performs during market volatilityFree Low Risk Swing Trade Opportunity List - Newser
What is the dividend policy of Anebulo Pharmaceuticals Inc. stockReal Time Outlook With High Returns - jammulinksnews.com
What are Anebulo Pharmaceuticals Inc. company’s key revenue driversEntry Signal Signals To Watch Now - jammulinksnews.com
Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation - 富途牛牛
Is Anebulo Pharmaceuticals Inc. a growth stock or a value stockAchieve exceptional returns with expert guidance - jammulinksnews.com
What institutional investors are buying Anebulo Pharmaceuticals Inc. stockAchieve rapid portfolio appreciation - jammulinksnews.com
Does Anebulo Pharmaceuticals Inc. stock perform well during market downturnsTremendous financial leverage - jammulinksnews.com
Published on: 2025-07-28 00:00:23 - jammulinksnews.com
What analysts say about GameSquare Holdings Inc. stockConsistently high yield - PrintWeekIndia
Top Healthcare Stocks in India Exclusive Stock Market PredictionsHigh-velocity capital appreciation - PrintWeekIndia
What drives MGP Ingredients Inc. stock priceFree Stock Market Trend Analysis - PrintWeekIndia
Is Anebulo Pharmaceuticals Inc. a good long term investmentExplosive wealth accumulation - PrintWeekIndia
Cannabis Use Disorder (CUD) Pipeline Market Research Report 2025 Featuring Aelis Farma, Anebulo Pharmaceuticals, and Indivior - GlobeNewswire Inc.
AppFolio Inc. Stock Analysis and ForecastLightning-fast capital gains - PrintWeekIndia
What drives Ares Management Corporation Preferred Security stock priceConsistent triple returns - Autocar Professional
Stocks with Low Risk and High Returns in India Stock Market ProsFree Stock Market Trend Analysis - PrintWeekIndia
Why Anebulo Pharmaceuticals Inc. stock is on top investor watchlistsExplosive portfolio gains - jammulinksnews.com
Anebulo Pharmaceuticals (NASDAQ:ANEB) Downgraded by Maxim Group to “Hold” - Defense World
What drives Anebulo Pharmaceuticals Inc. stock priceSuperior return velocity - PrintWeekIndia
Anebulo Pharmaceuticals’ (ANEB) “Hold” Rating Reaffirmed at Maxim Group - Defense World
Why The Chefs Warehouse Inc. stock attracts strong analyst attentionHigh Accuracy Alerts - Newser
Plus Therapeutics Soars 32.65% on $1.6M CPRIT Payment - AInvest
aneb - AInvest
What drives FBRT stock priceHigh-yield investments - Autocar Professional
GCM Securities Limited (535431) Stock RalliesConsistent wealth multiplication - Autocar Professional
Biotech Stocks Grab Attention Thanks To Major News Moves - Finimize
Anebulo Pharmaceuticals Inc Inc. (ANEB) Price Performance: A Technical Analysis Perspective - investchronicle.com
Healthcare Stocks Move in Intraday Session, Abivax Leads Gainers - AInvest
Anebulo Pharmaceuticals approves reverse stock split for going-private transaction - AInvest
Anebulo stock rises on plans to go-private (ANEB:NASDAQ) - Seeking Alpha
Best Stocks for Wealth Building Financial Success Stock PicksOver 200% growth - Autocar Professional
Anebulo Pharmaceuticals Inc Stock (ANEB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):